MedPath

Extended Access of Momelotinib in Adults With Myelofibrosis

Phase 2
Active, not recruiting
Conditions
Neoplasms
Post-polycythemia Vera Myelofibrosis (Post-PV MF)
Primary Myelofibrosis (PMF)
Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
Interventions
Drug: MMB
Registration Number
NCT03441113
Lead Sponsor
GlaxoSmithKline
Brief Summary

The primary objective of this study is to provide extended access and assess long-term safety of momelotinib (MMB) in participants with primary myelofibrosis (PMF) or post-polycythemia vera or post-essential thrombocythemia myelofibrosis (Post-PV/ET MF) enrolled in studies GS-US-352-0101 (NCT01969838), GS-US-352-1214 (NCT02101268), GS-US-352-1154 (NCT02124746), SRA-MMB-301 who are currently receiving treatment with MMB (available as 50mg,100 mg, 150 mg and 200 mg tablets) and have not experienced progression of disease. The secondary objective is to assess overall survival (OS) and leukemia free survival (LFS) in all subjects.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
237
Inclusion Criteria
  • Currently enrolled in Studies GS-US-352-0101, GS-US-352-1214, GS-US-352-1154, or SRA-MMB-301
  • Able to comprehend and willing to sign the informed consent form

Key

Read More
Exclusion Criteria
  • Known hypersensitivity to MMB, its metabolites, or formulation excipients

NOTE: Other protocol defined Inclusion/ Exclusion criteria may apply.

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cohort 3: Study GS-US-352-1154MMBParticipants will continue to receive the same dosage regimen as in the previous MMB study GS-US-352-1154 until MMB receives regulatory approval and is commercially available, or development of the product ceases..
Cohort 2: Study GS-US-352-1214MMBParticipants will continue to receive the same dosage regimen as in the previous MMB study GS-US-352-1214 until MMB receives regulatory approval and is commercially available, or development of the product ceases.
Cohort 4: Study SRA-MMB-301MMBParticipants will continue to receive the same dosage regimen as in the previous MMB study SRA-MMB-301 until MMB receives regulatory approval and is commercially available, or development of the product ceases.
Cohort 1: Study GS-US-352-0101MMBParticipants will continue to receive the same dosage regimen as in the previous MMB study GS-US-352-0101 until MMB receives regulatory approval and is commercially available, or development of the product ceases.
Primary Outcome Measures
NameTimeMethod
Number of Participants Who Had Access to, and Received the InterventionParticipants will be assessed every 12 weeks until discontinuation. Participation in this extended access study has been an average of approximately 8 months.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (114)

IC Irvine Health

🇺🇸

Orange, California, United States

GSK Investigational Site

🇬🇧

Oxford., United Kingdom

Stanford Hospital and Clinics

🇺🇸

Stanford, California, United States

Mayo Clinic Florida

🇺🇸

Jacksonville, Florida, United States

Winship Cancer Institute, Emory University

🇺🇸

Atlanta, Georgia, United States

Northwest Oncology & Hematology - Rolling Meadows

🇺🇸

Rolling Meadows, Illinois, United States

Saint Agnes Hospital

🇺🇸

Baltimore, Maryland, United States

Washington University School of Medicine Siteman Cancer Center

🇺🇸

Saint Louis, Missouri, United States

Cleveland Clinic Foundation

🇺🇸

Cleveland, Ohio, United States

Icon Cancer Care Wesley

🇦🇺

Hyde Park, Queensland, Australia

Flinders Medical Centre

🇦🇺

Adelaide, South Australia, Australia

Universitätsklinikum Dresden

🇩🇪

Dresden, Germany

Azienda Ospedaliera Ospedali Riuniti Marche Nord

🇮🇹

Pesaro, Pesaro E Urbino, Italy

Inje University Haeundae Paik Hospital

🇰🇷

Busan, Busan Gwang'yeogsi [Pusan-Kwangyokshi], Korea, Republic of

Severance Hospital

🇰🇷

Seoul, Seoul Teugbyeolsi [Seoul-T'ukpyolshi], Korea, Republic of

Hospital de Día Quirónsalud Zaragoza

🇪🇸

Zaragoza, Spain

Imperial College Healthcare NHS Trust

🇬🇧

London, United Kingdom

Universitätsklinikum Schleswig-Holstein - Campus Lübeck

🇩🇪

Lübeck, Schleswig-Holstein, Germany

Royal Perth Hospital

🇦🇺

Perth, Western Australia, Australia

Ordensklinikum Linz Elisabethinen

🇦🇹

Linz, Upper Austria, Austria

Frankston Hospital

🇦🇺

Frankston, Victoria, Australia

Medizinische Universität Wien

🇦🇹

Wien, Vienna, Austria

Centre Hospitalier Universitaire de Liège Site Sart Tilman

🇧🇪

Liège, Belgium

UMHAT Dr. Georgi Stranski EAD

🇧🇬

Pleven, Bulgaria

Dél-pesti Centrumkórház - Országos Hematológiai és Infektológiai Intézet

🇭🇺

Budapest, Pest, Hungary

Emek Medical Center

🇮🇱

Afula, Israel

Semmelweis Egyetem I. sz. Belgyogyaszati Klinika, Hematologia

🇭🇺

Budapest, Hungary

Hackensack University Medical Center

🇺🇸

Hackensack, New Jersey, United States

Dana-Farber Cancer Institute (DFCI)

🇺🇸

Boston, Massachusetts, United States

Barzilai Medical Center, Hematology Institute

🇮🇱

Ashkelon, Israel

Spitalul Clinic Municipal Filantropia Craiova

🇷🇴

Craiova, Romania

Raffles Hospital

🇸🇬

Singapore, Singapore

Universitaire Ziekenhuis Leuven

🇧🇪

Leuven, Belgium

University Multiprofile Hospital for Active Treatment St. Ivan Rilski

🇧🇬

Sofia, Bulgaria

Szpital Wojewódzki w Opolu

🇵🇱

Opole, Opolskie, Poland

Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespól Szpitali Miejskich

🇵🇱

Chorzów, Poland

Institutul Clinic Fundeni

🇷🇴

Bucuresti, Romania

Chang Gung Memorial Hospital - Linkou Branch

🇨🇳

Taoyuan, Taiwan

The Alfred Hospital

🇦🇺

Melbourne, Victoria, Australia

Peter MacCallum Cancer Centre

🇦🇺

Parkville, Victoria, Australia

Algemeen Ziekenhuis Sint-Jan Brugge-Oostende - Campus Sint-Jan

🇧🇪

Brugge, West-Vlaanderen, Belgium

Multiprofile Hospital for Active Treatment Ruse

🇧🇬

Ruse, Bulgaria

Samodzielny Publiczny Szpital Kliniczny nr 1 w Lub

🇵🇱

Lublin, Poland

Szpital Uniwersytecki w Krakowie, Oddzial Kliniczny Hematologii

🇵🇱

Małogoskie, Poland

Institutul Oncologic Prof. Dr. Ion Chiricuţă

🇷🇴

Cluj-Napoca, Romania

Institutul Regional De Oncologie IASI

🇷🇴

Iasi, Romania

Ziekenhuis Netwerk Antwerpen Stuivenberg

🇧🇪

Antwerp, Belgium

National Specialized Hospital for Active Treatment of Haematologic Diseases

🇧🇬

Sofia, Bulgaria

Szabolcs-Szatmár-Bereg Megyei Kórházak És Egyetemi Oktatókórház

🇭🇺

Nyíregyháza, Szabolcs-Szatmár-Bereg, Hungary

Hadassh Medical Organization

🇮🇱

Jerusalem, Israel

Meir Medical Center

🇮🇱

Kfar Saba, Israel

Spitalul Clinic Coltea

🇷🇴

Bucuresti, Romania

Singapore General Hospital

🇸🇬

Singapore, Singapore

Kaohsiung Chang Gung Memorial Hospital

🇨🇳

Kaohsiung, Taiwan

Maastricht University Medical Centre

🇳🇱

Maastricht, Limburg, Netherlands

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

Carmel Medical Center

🇮🇱

Haifa, Israel

Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza

🇵🇱

Brzozów, Podkarpacki, Poland

Uniwersyteckie Centrum Kliniczne

🇵🇱

Gdańsk, Pomoskie, Poland

Samodzielny Publiczny Zaklad Opieki Zdrowotnej MSWiA w Poznaniu im. Ledwika Bierkowskiego

🇵🇱

Poznań, Poland

NHS Lanarkshire

🇬🇧

Airdrie, Scotland, United Kingdom

University Hospitals Bristol and Weston NHS Foundation Trust

🇬🇧

Bristol, England, United Kingdom

Mayo Clinic - Department of Hematology

🇺🇸

Rochester, Minnesota, United States

Mayo Clinic Building - Phoenix

🇺🇸

Milwaukee, Wisconsin, United States

University of Colorado Cancer Center

🇺🇸

Aurora, Colorado, United States

Moffitt Cancer Center

🇺🇸

Tampa, Florida, United States

Research Institute of the McGill University Health Centre

🇨🇦

Montréal, Quebec, Canada

Aalborg University Hospital

🇩🇰

Aalborg, Denmark

Sir Mortimer B. Davis Jewish General Hospital

🇨🇦

Montréal, Canada

Princess Margaret Cancer Centre

🇨🇦

Toronto, Canada

Institut Paoli Calmettes

🇫🇷

Marseille, France

Gentofte Hospital

🇩🇰

Herlev, Denmark

Hopital Saint-Louis

🇫🇷

Paris, ILE-De-FRANCE, France

CHRU Huriez Lille

🇫🇷

Lille Cedex, France

Institut Universitaire du Cancer

🇫🇷

Toulouse Cedex 9, France

Universitätsklinikum Aachen

🇩🇪

Aachen, Nordrhein-Westfalen, Germany

Centre Hospitalier Lyon Sud

🇫🇷

Pierre Bénite Cedex, France

Centre Hospitalier Le Mans

🇫🇷

Le Mans, Pays De La Loire, France

Hôpital Haut-Lévêque

🇫🇷

Pessac Cedex, France

Universitätsklinikum Halle

🇩🇪

Halle, Sachsen-Anhalt, Germany

University Hospital of Cologne

🇩🇪

Cologne, Germany

Petz Aladár Egyetemi Oktató Kórház - Győr

🇭🇺

Győr, Gyor-Moson-Sopron, Hungary

Universitätsklinikum Leipzig

🇩🇪

Leipzig, Germany

Szent Borbála Kórház

🇭🇺

Tatabánya, Komárom-Esztergom, Hungary

Debreceni Egyetem Klinikai Kozpont, Belgyogyaszati Klinika, Haematologiai Tanszek

🇭🇺

Debrecen, Hungary

Somogy Megyei Kaposi Mor Oktató Kórház

🇭🇺

Kaposvár, Hungary

Azienda Ospedaliero - Universitaria Careggi

🇮🇹

Firenze, Florence, Italy

Azienda Socio Sanitaria Territoriale Monza - Ospedale San Gerardo

🇮🇹

Monza, Monza E Brianza, Italy

Azienda Ospedaliero-Universitaria Citta della Salute e della Scienza di Torino

🇮🇹

Torino, Turin, Italy

Azienda Ospedaliero Universitaria di Bologna Policlinico Sant'Orsola-Malpighi

🇮🇹

Bologna, Italy

Azienda Ospedaliera Ordine Mauriziano di Torino

🇮🇹

Torino, Turin, Italy

Azienda Ospedaliera Universitaria San Martino

🇮🇹

Genova, Italy

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

🇮🇹

Milano, Italy

Umberto I - Policlinico di Roma

🇮🇹

Roma, Italy

Catholic University of Korea Seoul Saint Mary's Hospital

🇰🇷

Seoul, Korea, Republic of

Azienda Ospedaliera Universitaria Federico II

🇮🇹

Napoli, Italy

IRCCS Centro di Riferimento Oncologico di Basilicata

🇮🇹

Potenza, Italy

Ospedale Policlinico Giambattista Rossi Borgo Roma

🇮🇹

Verona, Italy

Kyungpook National University Hospital

🇰🇷

Daegu, Daegu Gwang'yeogsi, Korea, Republic of

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

Policlinica de Diagnostic Rapid SA

🇷🇴

Braşov, Romania

Hospital Universitario Ramón y Cajal

🇪🇸

Madrid, Spain

Hospital Universitari Vall d'Hebron

🇪🇸

Barcelona, Spain

Hospital Universitario 12 de Octubre

🇪🇸

Madrid, Spain

Hospital Germans Trias i Pujol

🇪🇸

Badalona, Barcelona, Spain

Institut Hospital del Mar d'Investigacions Mèdiques

🇪🇸

Barcelona, Spain

Hospital Universitario Puerta de Hierro Majadahonda

🇪🇸

Madrid, Spain

Clínica Universidad de Navarra

🇪🇸

Pamplona, Spain

Kaohsiung Medical University Chung-Ho Memorial Hospital

🇨🇳

Kaohsiung, Taiwan

University Hospital of Wales

🇬🇧

Cardiff, United Kingdom

Oxford University Hospitals NHS Trust

🇬🇧

Oxford, United Kingdom

Johannes Gutenberg-Universität Mainz

🇩🇪

Mainz, Germany

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Montefiore Medical Center

🇺🇸

Bronx, New York, United States

© Copyright 2025. All Rights Reserved by MedPath